Sage Journals: Discover world-class research

Open access

Review article

First published 2023-2

Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review

Bianca Raffaelli, Roberto De Icco, Michele Corrado [...]

Cephalalgia

Retricted access

Research article

First published 2011-5

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

S Gopal, U Vijapurkar, P Lim [...]

Journal of Psychopharmacology

Open access

Research article

First published 2026

The role of expectations and tailored feedback on the open-label Placebo effect

Kirsten Barnes, Kate Faasse

Journal of Health Psychology

Free access

Research article

First published 2006-7

Add-on Quetiapine for Bipolar Depression: A 12-Month Open-Label Trial

Roumen Milev, Gebrehiwot Abraham, Juveria Zaheer

The Canadian Journal of Psychiatry

Open access

Research article

First published 2018-8

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus

A Doria, D Bass, A Schwarting [...]

Lupus

Retricted access

Research article

First published 2010-8

Oros Methylphenidate in the Treatment of Adults with Adhd: A 6-Month,Open-Label,Follow-Up Study

Barrie K. Marchant, Frederick W. Reimherr, Corinne Halls [...]

Annals of Clinical Psychiatry

Open access

Research article

First published 2020-2

A Long-Term,Open-Label,Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD

Lenard A. Adler, Glen Frick, Brian Yan

Journal of Attention Disorders

Retricted access

Research article

First published 2023-07-18

Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer’s Disease: Open-Label,Extension Study

Yu Nakamura, Takumi Omori, Rei Kim [...]

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2005-09

Mirtazapine treatment of Generalized Anxiety Disorder: a fixed dose,open label study

Francesco Gambi, Domenico De Berardis, Daniela Campanella [...]

Journal of Psychopharmacology

Free access

Research article

First published 2020-5

Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week,open-label extension study

Stewart J Tepper, Messoud Ashina, Uwe Reuter [...]

Cephalalgia

Search results